- Home
- BEATW vs FUSB Comparison
BEATW vs FUSB Comparison
Compare BEATW & FUSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEATW
- FUSB
- Stock Information
- Founded
- BEATW 2015
- FUSB 1952
- Country
- BEATW United States
- FUSB United States
- Employees
- BEATW 20
- FUSB N/A
- Industry
- BEATW Retail: Computer Software & Peripheral Equipment
- FUSB Major Banks
- Sector
- BEATW Technology
- FUSB Finance
- Exchange
- BEATW Nasdaq
- FUSB Nasdaq
- Market Cap
- BEATW N/A
- FUSB N/A
- IPO Year
- BEATW N/A
- FUSB N/A
- Fundamental
- Price
- BEATW $0.51
- FUSB $13.45
- Analyst Decision
- BEATW
- FUSB
- Analyst Count
- BEATW 0
- FUSB 0
- Target Price
- BEATW N/A
- FUSB N/A
- AVG Volume (30 Days)
- BEATW 4.7K
- FUSB 6.6K
- Earning Date
- BEATW 03-14-2025
- FUSB 04-23-2025
- Dividend Yield
- BEATW N/A
- FUSB 2.07%
- EPS Growth
- BEATW N/A
- FUSB N/A
- EPS
- BEATW N/A
- FUSB 1.33
- Revenue
- BEATW N/A
- FUSB $39,110,000.00
- Revenue This Year
- BEATW N/A
- FUSB N/A
- Revenue Next Year
- BEATW N/A
- FUSB N/A
- P/E Ratio
- BEATW N/A
- FUSB $10.15
- Revenue Growth
- BEATW N/A
- FUSB N/A
- 52 Week Low
- BEATW $0.50
- FUSB $8.75
- 52 Week High
- BEATW $0.62
- FUSB $14.30
- Technical
- Relative Strength Index (RSI)
- BEATW N/A
- FUSB 51.81
- Support Level
- BEATW N/A
- FUSB $13.41
- Resistance Level
- BEATW N/A
- FUSB $13.60
- Average True Range (ATR)
- BEATW 0.00
- FUSB 0.13
- MACD
- BEATW 0.00
- FUSB -0.02
- Stochastic Oscillator
- BEATW 0.00
- FUSB 33.33
About BEATW Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.